WallStreetZen

NYSE: LIN
Linde Plc Stock

$290.91-0.31 (-0.11%)
Updated Jun 14, 2021
LIN Price
$290.91
Fair Value Price
N/A
Market Cap
$151.33B
52 Week Low
$204.02
52 Week High
$305.71
P/E
52.42x
P/B
3.27x
P/S
5.28x
PEG
1.78x
Dividend Yield
1.03%
Revenue
$27.75B
Earnings
$2.91B
Gross Margin
43.8%
Operating Margin
14.3%
Profit Margin
10.5%
Debt to Equity
0.81
Operating Cash Flow
$8B
Beta
0.96
Next Earnings
N/A
Ex-Dividend
Jun 2, 2021
Next Dividend
Jun 17, 2021

LIN Overview

Zen Score

High
Medium
Low
33
Industry average

Reasons for this score

LIN ($290.91) is trading below its intrinsic value of $600.42, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
LIN is poor value based on its earnings relative to its share price (52.42x), compared to the US market average (27.51x)
Valuation
LIN is poor value based on its earnings relative to its share price (52.42x), compared to the US Specialty Chemicals industry average (33.61x)
Valuation

1 of 10

LIN News

Valuation

LIN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
52.42x
Industry
33.61x
Market
27.51x
LIN is poor value based on its earnings relative to its share price (52.42x), compared to the US market average (27.51x)
Valuation
LIN is poor value based on its earnings relative to its share price (52.42x), compared to the US Specialty Chemicals industry average (33.61x)
Valuation

LIN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.27x
Industry
4.2x
LIN is good value based on its book value relative to its share price (3.27x), compared to the US Specialty Chemicals industry average (4.2x)
Valuation

LIN price to earnings growth (PEG)

For valuing profitable companies with growth potential
LIN is poor value relative to its rate of earnings growth, measured by PEG ratio (1.78x)
Valuation

LIN's financial health

Profit margin

Revenue
$7.2B
Net Income
$980.0M
Profit Margin
13.5%
LIN's Earnings (EBIT) of $3.97B can safely cover interest payments on company debt ($15.75B)
Financials
LIN's profit margin has increased (+2.1%) in the last year from (8.4%) to (10.5%)
Financials

Assets to liabilities

Assets
$85.0B
Liabilities
$37.4B
Debt to equity
0.34
LIN's short-term liabilities ($15.03B) exceed its short-term assets ($11.13B)
Financials
LIN's long-term liabilities ($22.33B) exceed its short-term assets ($11.13B)
Financials
LIN's debt to equity ratio (0.81) is considered high
Financials

Cash flow

Operating
$2.1B
Investing
-$751.0M
Financing
-$970.0M
LIN's operating cash flow ($8.19B) is sufficient to service the company's debt ($15.75B)
Financials

Linde Stock FAQ

What is Linde's quote symbol?

(NYSE: LIN) Linde trades on the NYSE under the ticker symbol LIN. Linde stock quotes can also be displayed as NYSE: LIN.

What is the 52 week high and low for Linde (NYSE: LIN)?

(NYSE: LIN) Linde's 52-week high was $305.71, and its 52-week low was $204.02. It is currently -4.84% from its 52-week high and 42.59% from its 52-week low.

How much is Linde stock worth today?

(NYSE: LIN) Linde currently has 520,208,493 outstanding shares. With Linde stock trading at $290.91 per share, the total value of Linde stock (market capitalization) is $151.33B.

Linde stock was originally listed at a price of $165.47 in Oct 31, 2018. If you had invested in Linde stock at $165.47, your return over the last 2 years would have been 75.81%, for an annualized return of 32.59%.

How much is Linde's stock price per share?

(NYSE: LIN) Linde stock price per share is $290.91 today (as of Jun 14, 2021).

What is Linde's Market Cap?

(NYSE: LIN) Linde's market cap is $151.33B, as of Jun 15, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Linde's market cap is calculated by multiplying LIN's current stock price of $290.91 by LIN's total outstanding shares of 520,208,493.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.